Anti-cancer drug price control brings significant savings for consumers, totaling Rs 3,540 crore.
Read More
Inovio stock rise: Best proven strategy for investors
Inovio stock rise highlights the impact of plasmid DNA drug approval on market performance.
Read MoreSun Pharma quarterly profit shows negative trend after acquisition
Sun Pharma quarterly profit has fallen due to the Organon acquisition charge, impacting their financial outlook.
Read MoreGiredestrant launch details: Is it the best move for Roche?
Giredestrant launch details are crucial for Roche's future. Find out what was revealed during the Q3 earnings call.
Read More
Drug Price Gap: Why the 16% Cap is Wrong
Drug price gap raises concerns as SC questions Centre's policies.
Read More
